Results 81 to 90 of about 129,511,766 (119)

Phosphorylation at Y317 on Syk negatively regulates both ITAM- and hemITAM-mediated signaling and function in platelets

open access: yesBlood Advances
: Spleen tyrosine kinase (Syk) is expressed in a variety of hematopoietic cells. Its phosphorylation regulates downstream signaling events upon stimulation of receptors containing an immunoreceptor tyrosine-based activation motif (ITAM), like ...
Manal A. Elzoheiry   +5 more
doaj   +1 more source

Antitumor activity of chLpMab‐2, a human–mouse chimeric cancer‐specific antihuman podoplanin antibody, via antibody‐dependent cellular cytotoxicity

open access: yesCancer Medicine, 2017
Human podoplanin (hPDPN), a platelet aggregation‐inducing transmembrane glycoprotein, is expressed in different types of tumors, and it binds to C‐type lectin‐like receptor 2 (CLEC‐2).
Mika K. Kaneko   +9 more
doaj   +1 more source

Distinct extracellular architectures shape mechanical persistence in GPVI and CLEC-2 receptor assemblies.

open access: yesPLoS Computational Biology
Glycoprotein VI (GPVI) and C-type lectin-like receptor 2 (CLEC-2) are platelet-activating receptors whose extracellular organization contributes to receptor association and signaling during thrombus formation, yet how alternative receptor architectures ...
Yao Zhang   +3 more
doaj   +1 more source

Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials

open access: yesBlood Vessels, Thrombosis & Hemostasis
: Sickle cell disease (SCD) is an inherited hemolytic disorder characterized by a mutation in β-globin, resulting in hemoglobin polymerization, red blood cell rigidity, and a persistently activated endothelium that promotes thromboinflammation. Platelets
Joanne C. Alfred, Erica M. Sparkenbaugh
doaj   +1 more source

Development and characterization of anti‐glycopeptide monoclonal antibodies against human podoplanin, using glycan‐deficient cell lines generated by CRISPR/Cas9 and TALEN

open access: yesCancer Medicine, 2017
Human podoplanin (hPDPN), which binds to C‐type lectin‐like receptor‐2 (CLEC‐2), is involved in platelet aggregation and cancer metastasis. The expression of hPDPN in cancer cells or cancer‐associated fibroblasts indicates poor prognosis. Human lymphatic
Mika K. Kaneko   +10 more
doaj   +1 more source

C-type lectin-like receptor 2 (CLEC-2)-dependent dendritic cell migration is controlled by tetraspanin CD37

open access: yes, 2018
Contains fulltext : 197204.pdf (Publisher’s version ) (Open Access)
Winde, C.M. de   +8 more
openaire   +2 more sources

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Platelet CLEC-2: Roles Beyond Hemostasis

open access: yes, 2017
C-type lectin-like receptor 2 (CLEC-2) has been identified on the surface of platelets as a receptor for a platelet activating snake venom, rhodocytin/aggretin.
Yukio Ozaki   +5 more
core   +1 more source

C-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in mice

open access: yesC-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in mice
application/pdf ...
openaire   +3 more sources

Gut-derived Faecalibaculum rodentium exerts anti-cancer effects on colorectal cancer by modulating PDPN-CLEC-2 signaling pathway

open access: yesmSystems
Dynamic changes in microbial composition are related to the progression of colorectal cancer (CRC); however, specific microbes with anti-CRC properties have not been identified.
Xiaojuan Yang   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy